Oberste, L., Rüffer, F., Aydingül, O., Rink, J. und Heinzl, A. (2023). Designing user-centric explanations for medical imaging with informed machine learning. In , Design Science Research for a New Society: Society 5.0 : 18th International Conference on Design Science Research in Information Systems and Technology, DESRIST 2023, Pretoria, South Africa, May 31 – June
... read moreZercher, D., Jussupow, E. und Heinzl, A. (2023). When AI joins the team: A literature review on intragroup processes and their effect on team performance in team-AI collaboration. In , European Conference on Information Systems, ECIS 2023 : proceedings (S. 1–18). Conference of the European Colloid and Interface Society (ECIS) : Research Papers, AISeL: Atlanta,
... read moreRittel, M.F.; Schmidt, S.; Weis, C.-A.; Birgin, E.; van Marwick, B.; Rädle, M.; Diehl, S.J.; Rahbari, N.N.; Marx, A.; Hopf, C. Spatial Omics Imaging of Fresh-Frozen Tissue and Routine FFPE Histopathology of a Single Cancer Needle Core Biopsy: A Freezing Device and Multimodal Workflow. Cancers 2023, 15, 2676. https://doi.org/10.3390/cancers15102676 Published: 10 May 2023 Simple Summary
... read moreAbu Sammour, D., Cairns, J.L., Boskamp, T. et al. Spatial probabilistic mapping of metabolite ensembles in mass spectrometry imaging. Nat Commun 14, 1823 (2023). https://doi.org/10.1038/s41467-023-37394-z Published: 01 April 2023 Abstract Mass spectrometry imaging vows to enable simultaneous spatially resolved investigation of hundreds of metabolites in tissues, but it primarily relies on traditional ion images for
... read moreJudmann B, Wängler B, Schirrmacher R, Fricker G, Wängler C* (2023) Towards Radiolabeled EGFR-Specific Peptides: Alternatives to GE11. Pharmaceuticals, 16(2), 273. DOI: 10.3390/ph16020273. Abstract The human epidermal growth factor receptor (EGFR) is closely related to several cancer-promoting processes and overexpressed on a variety of tumor types, rendering it an important target structure for the imaging
... read moreEschbach RS, Hofmann M, Späth L, Unterrainer LM, Sheikh GT, Delker A, Lindner S, Jurkschat K, Wängler C, Wängler B, Schirrmacher R, Tiling R, Brendel M, Wenter V, Dekorsy FJ, Zacherl MJ, Todica A, Ilhan H, Grawe F, Cyran CC, Unterrainer M, Rübenthaler J, Knoesel T, Paul T, Boeck S, Westphalen CB, Spitzweg C, Auernhammer
... read moreJason Chiang, MD, PhD, Hiro Sparks, MD, Johann S. Rink, MD, M. Franca Meloni, MD, Frank Hao, MD, Kyung H. Sung, PhD, and Edward W. Lee, MD, PhD Journal of Vascular and Interventional Radiology https://doi.org/10.1016/j.jvir.2022.10.041 Available online 8 November 2022 Received 4 June 2022, Revised 29 September 2022, Accepted 28 October 2022, Available online 8
... read moreDamerow H, Wängler B, Schirrmacher R, Fricker G, Wängler C* (2023) Synthesis of a new bifunctional cross-bridged chelating agent, peptide conjugation, and comparison of 68Ga-labeling and complex stability characteristics with established chelators. ChemMedChem 18(1), e202200495. DOI: 10.1002/cmdc.202200495. Graphical Abstract The new backbone-modified bifunctional cross-bridged chelating agent CB-DO2A-GA was developed, introduced into the peptide Tyr3-octreotate and
... read moreDamerow H, Cheng X, von Kiedrowski V, Schirrmacher R, Wängler B, Fricker G, Wängler C* (2022) Toward Optimized 89Zr-Immuno-PET: Side-by-Side Comparison of [89Zr]Zr-DFO-, [89Zr]Zr-3,4,3-(LI-1,2-HOPO)- and [89Zr]Zr-DFO*-Cetuximab for Tumor Imaging – Which Chelator is the Most Suitable? Pharmaceutics 14(10), 2114. DOI: 10.3390/pharmaceutics14102114. Published: 4 October 2022 https://doi.org/10.3390/pharmaceutics14102114 Abstract 89Zr represents a highly favorable positron emitter for
... read moreWängler C, Beyer L, Bartenstein P, Wängler B, Schirrmacher R, Lindner S (2022) Favorable SSTR Subtype Selectivity of SiTATE: New momentum for clinical [18F]SiTATE PET. EJNMMI Radiopharmacy and Chemistry, 7(1), 22. DOI: 10.1186/s41181-022-00176-x. Published 05 September 2022 DOI: https://doi.org/10.1186/s41181-022-00176-x
... read more